In this view-on-demand webinar you will:

  • Learn about a new end-to-end NGS solution for precision oncology biomarker testing that can deliver results in as little as 24 hours
  • Hear results of a multicentric study evaluating performance of the test
  • Hear from an oncologist’s point of view the importance of timely availability of clinically relevant biomarker data for therapy management and the potential clinical impact for patients


Nicola Normanno, MD
Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute—Fondazione G. Pascale, Naples, Italy

Luca Quagliata, PhD, BCMAS
Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific

Paul Hofman, MD, PhD
Professor of Pathology, Laboratory of Clinical and Experimental Pathology at Louis Pasteur Hospital, Nice, France

Please fill out the brief form below to access this webinar.

(*Indicates a mandatory field)